Hoffman RM (2011) Screening for prostate cancer. N Engl J Med 365:2013–2019
Hood LE, Omenn GS, Moritz RL, Aebersold R, Yamamoto KR et al (2012) New and improved
proteomics technologies for understanding complex biological systems: addressing a
grand challenge in the life sciences. Proteomics 12:2773–2783
Huang L-C, Wu X, Chen JY (2013) Predicting adverse drug reaction profiles by integrating protein
interaction networks with drug structures. Proteomics 13:313–324
Huhn C, Selman MHJ, Ruhaak R, Deelder AM, Wuhrer M (2009) IgG glycosylation analysis.
Proteomics 9:882–913
Huillet C, Adrait A, Lebert D, Picard G, Trauchessec M et al (2012) Accurate quantification of
cardiovascular biomarkers in serum using protein standard absolute quantification (PSAQ™)
and selected reaction monitoring. Mol Cell Proteomics 11:1–12
Imami K, Suguiami N, Imamura H, Wakabayashi M, Tomita M et al (2012) Temporal profiling of
Lapatinib-suppressed phosphorylation signals in EGFR/HER2 pathways. Mol Cell Proteomics
11:1741–1757. doi:10.1074/mcp.M112.019919
Jelakovic B, Nikolic J, Radovanovic Z, Nortier J, Cosyns J-P, Grollmann AP et al (2014) Con-
sensus statement on screening, diagnosis, classification and treatment of endemic (Balkan)
nephropathy. Nephrol Dial Transplant 29:2020–2027
Jesse S, Rist W, Steinacker P, Soinen H, Herukka S-K et al (2012) iTRAQ and multiple reaction
monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with
Parkinson’s disease dementia. Exp Neurol 234:99–505
Jones DR, Moussaud S, McLean P (2014) Targeting Heat shock proteins to modulate alpha-
synuclein toxicity. Ther Adv Neurol Disord 7:33–51
Josic D (2014) Strategies for complete proteomic analysis of hydrophobic proteins in complex
biological samples-hide-and seek. J Data Mining Genomics Proteomics 5:e111. doi:10.4172/
2153-0602.1000e111
Josic D, Kovac S (2009) Molecular imaging mass spectrometry. Kem Ind 58:207–213
Josic D, Clifton JG, Kovac S (2008) Membrane proteins as diagnostic biomarkers and targets for
new therapies. Curr Opin Mol Ther 10:116–123
Kang S, Shim HS, Lee JS, Kim DS, Kim HY et al (2010) Molecular proteomic imaging of
tumor interfaces by mass spectrometry. J Proteome Res 9:1157–1164
Kaur P, Rizk NM, Ibrahim S, Younes N, Uppal A, Dennis K, Karve T, Blakeslee K, Kwagyan J,
Zirie M, Ressom HW, Cheema AK (2012) iTRAQ-based quantitative protein expression
profiling and MRM verification of markers in type 2 diabetes. J Proteome Res 11:5527–5539
Kim MS, Zhong Y, Yachida S, Rajeshkumar NV, Abel M et al (2014a) Heterogeneity of
pancreatic cancer metastases in a single patient revealed by quantitative proteomics.
Mol Cell Proteomics 13:2803–2811
Kim SJ, Chae S, Kim H, Mun DG, Back S, Choi HY, Park KS, Hwang D, Choi SH, Lee SW
(2014b) A protein profile of visceral adipose tissues linked to early pathogenesis of
type 2 diabetes mellitus. Mol Cell Proteomics 13:811–822
Koomen J, Haura EB, Bepler G, Suthphen R, Remly-Wood ER, Benson K et al (2008) Proteomic
contributions to personalized cancer care. Mol Cell Proteomics 7:1780–1794
Krasteva ME, Georgieva EL (2006) Germline p53 single base changes associated with
Balkan endemic nephropathy. Biochem Biophys Res Commun 342:561–567
Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R et al (2009) Circos: an information
aesthetic for comparative genomics. Genome Res 19:1639–1645
Lane L, Bairoch A, Beavis RC, Deutsch EW, Gaudet P, Lundberg E, Omenn GS (2014) Metrics
for the Human Proteome Project 20132014 and strategies for finding missing proteins.
J Proteome Res 13:15–20
Lawson EL, Clifton JG, Huang F, Li X, Hixson DC, Josic D (2006) Use of magnetic beads with
immobilized monoclonal antibodies or isolation of highly pure plasma membranes. Electro-
phoresis 27:2747–2758
214 D. Josic ́and U. Andjelkovic ́